There are several studies focused on the association of KL-6 with other IIMs, mainly polymyositis (PM) and dermatomyositis (DM), that indicate a relevant role of this marker in the development and progression of ILD in this context12,16,17,25–30. This evidence concerns the gene MUC1 and dermatomyositis.